Episode Details
Back to Episodes
Johnson & Johnson: Safe Bet in Uncertain Times | Business and Finance News
Description
Even as tensions ease and gas prices fall, economists warn a recession looms — and savvy investors are preparing. Johnson & Johnson stands out as a recession-resistant gem, anchored in healthcare, where medical needs don’t vanish in tough times. With a vast drug portfolio, a strong pipeline, and a history of weathering storms — from patent expirations to lawsuits — JNJ keeps delivering. Their solid finances, top credit rating, and 64-year streak of dividend growth make them a dependable play during economic uncertainty.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/259b5a0c1209e371